Preclinical specificity & activity of a fully human 41BB-expressing anti-CD19 CART- therapy for treatment-resistant autoimmune disease
针对治疗耐药性自身免疫性疾病的全人 41BB 表达抗 CD19 CART 疗法的临床前特异性和活性
期刊:Molecular Therapy-Methods & Clinical Development
影响因子:
doi:10.1016/j.omtm.2024.101267
Binghao J Peng, Andrea Alvarado, Hangameh Cassim, Soprina Guarneri, Steven Wong, Jonathan Willis, Julia SantaMaria, Ashley Martynchuk, Victoria Stratton, Darshil Patel, Chien-Chung Chen, Yan Li, Gwendolyn K Binder, Rebecca Dryer-Minnerly, Jinmin Lee, Samik Basu
